Markets:

Overview

News

Currencies

International

Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

112.14 +0.16 (+0.14%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Steve E. Krognes Joins Guardant Health Board of Directors

July 07, 2022

From Guardant Health, Inc.

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 27, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture

June 13, 2022

From Guardant Health, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022 ↗

June 03, 2022

Via Benzinga

Guardant Health to Participate in Upcoming June Investor Conferences

May 26, 2022

From Guardant Health, Inc.

Via Business Wire

First Guardant Health Liquid Biopsy Testing Service in Europe Now Operational at Vall d’Hebron Institute of Oncology

May 25, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Present New Data from its Broad Portfolio of Blood Tests at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

May 23, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022

May 21, 2022

From Guardant Health, Inc.

Via Business Wire

Recap: Guardant Health Q4 Earnings ↗

February 23, 2022

Guardant Health (NASDAQ:GH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:03 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 10, 2022

Gainers

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

May 09, 2022

Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.

Via Benzinga

What 6 Analyst Ratings Have To Say About Guardant Health ↗

May 06, 2022

Over the past 3 months, 6 analysts have published their opinion on Guardant Health (NASDAQ:GH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

55 Stocks Moving In Friday's Mid-Day Session ↗

May 06, 2022

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.

Via Benzinga

92 Biggest Movers From Friday ↗

May 09, 2022

Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...

Via Benzinga

Guardant Health Reports First Quarter 2022 Financial Results

May 05, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces Shield™ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults

May 02, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in the BofA Securities 2022 Healthcare Conference

April 28, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Report First Quarter Financial Results on May 5, 2022

April 13, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Presents New Data Showing Blood Test Highly Accurate in Detecting Multiple Cancers at the American Association for Cancer Research Annual Meeting

April 11, 2022

From Guardant Health, Inc.

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 07, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Guardant Health Announces Partnership with Epic to Streamline Access to Company’s Broad Portfolio of Cancer Tests

April 04, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Response to Frivolous and Retaliatory Lawsuit Filed by Illumina

March 17, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Receives Regulatory Approval for Guardant360® CDx in Japan

March 14, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health's Return On Capital Employed Overview ↗

March 11, 2022

According to data from Benzinga Pro, during Q4, Guardant Health's (NASDAQ:GH) reported sales totaled $108.11 million. Despite a 32.75% increase in earnings, the company posted a...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

February 24, 2022

SVB Leerink lowered Guardant Health, Inc. (NASDAQ: GH) price target from $170 to $140. Guardant Health shares dropped 5.7% to $56.22 in pre-market trading.

Via Benzinga

Guardant Health Reports Fourth Quarter 2021 Financial Results and Provides 2022 Outlook

February 23, 2022

From Guardant Health, Inc.

Via Business Wire

The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗

February 23, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...

Via Benzinga

Guardant Health to Participate in Upcoming Investor Conferences

February 07, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

February 01, 2022

From Guardant Health, Inc.

Via Business Wire

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.